Sosei Group Corp. will receive a $3.75 million milestone payment under the 2019 multi-target research collaboration and license agreement with Genentech, a member of the Roche Group. The discovery-based payment is related to progression of a potential first-in-class project targeting an undisclosed G protein-coupled receptor (GPCR). Genentech will now be responsible for further development and commercialization of this potential new medicine.  The milestone is the latest of an ongoing collabo...